Newsroom

Sorted by: Latest

-

Nanyang Biologics and Precisya Global Inc Announce Strategic Collaboration to Validate Natural Compounds Against Genetic Disease Markers

SINGAPORE & WILMINGTON, Del.--(BUSINESS WIRE)--Nanyang Biologics (NYB) and Precisya Global Inc (PGI) announce a strategic collaboration to leverage our technologies in validating potential therapeutic benefits of natural compounds against genetically identified risk factors and predispositions for chronic diseases. The partnership combines PGI's genomic big data analytics with NYB's natural compound libraries and AI capabilities. The collaboration will leverage DTIGN (Drug-Target Interaction Gr...
-

New Study from UK’s Largest Virtual ADHD Service Validates Role of Objective Testing in Delivering Personalized, High-Quality Remote ADHD Care

LONDON & PRAGUE--(BUSINESS WIRE)--New Study from UK’s Largest Virtual ADHD Service Validates Role of Objective Testing in Delivering Personalized, High-Quality Remote ADHD Care...
-

From "Export" to "Co-Creation": How SOUEAST Drives Globalization With User-Oriented Strategies

SHANGHAI--(BUSINESS WIRE)--The global automotive industry is undergoing a seismic shift, with automakers like SOUEAST leading the charge from traditional export-driven models to innovative, user-oriented globalization strategies. On April 24, SOUEAST took a bold step forward by hosting its inaugural Global EASE DAY in Shanghai, highlighting its commitment to user co-creation and localization. This event positioned SOUEAST as a dynamic global brand that prioritizes adaptability, deep market inte...
-

Cameco annonce l'élection des administrateurs

SASKATOON, Saskatchewan--(BUSINESS WIRE)--Cameco (TSX : CCO; NYSE : CCJ) a annoncé l'élection de dix membres du conseil d'administration lors de sa réunion annuelle du 9 mai 2025. Les actionnaires ont élu les membres du conseil d'administration Daniel Camus, Tammy Cook-Searson, Catherine Gignac, Tim Gitzel, Marie Inkster, Kathryn Jackson, Don Kayne, Peter Kukielski, Dominique Minière et Leontine van Leeuwen-Atkins. Résultats du vote pour les administrateurs de Cameco Candidat Votes pour % votes...
-

Sixth Annual Nursing Now Ontario Awards Celebrate Outstanding Nurses

TORONTO--(BUSINESS WIRE)--Three exceptional nurses, celebrated for their unwavering dedication to improving peoples’ lives and advancing Ontario’s health-care system, will be honoured at the sixth annual Nursing Now Ontario Awards (NNOA). These prestigious awards recognize excellence in nursing across three categories: nurse practitioner (NP), registered nurse (RN), and registered practical nurse (RPN). Aligned with National Nursing Week (May 12-18, 2025), the awards spotlight the critical role...
-

GoHealth, Inc. (GOCO) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of GoHealth, Inc. (“GoHealth” or the “Company”) (NASDAQ: GOCO) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN GOHEALTH, INC. (GOCO), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at h...
-

Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN IOVANCE BIOTHERAPEUTICS, INC. (IOVA), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss yo...
-

Iovance Biotherapeutics’ (IOVA) Annual Maintenance: Assurances Collide with Adverse Disclosure as Shares Plunge 44% – Hagens Berman

SAN FRANCISCO--(BUSINESS WIRE)--In a dramatic turn for Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), investors watched the company’s shares plunge nearly 44% on May 9, 2025, after the San Carlos-based cell therapy pioneer reported a first-quarter revenue miss that sharply contradicted earlier upbeat assurances from management. Hagens Berman is now investigating whether Iovance violated U.S. securities laws and urges Iovance investors who suffered substantial losses to submit your losses now. Th...
-

Pembina Pipeline Corporation Reports Voting Results from 2025 Annual Meeting of Shareholders

CALGARY, Alberta--(BUSINESS WIRE)--Pembina Pipeline Corporation ("Pembina" or the "Company") (TSX: PPL; NYSE: PBA) reported the voting results from its annual meeting of shareholders held virtually on May 9, 2025 (the "Meeting"). Each of the matters voted upon at the Meeting is discussed in detail in the Company's Management Information Circular dated March 20, 2025 (the "Information Circular"), which is available on the Company's website under 'Investors – Presentations & Events' at www.pe...
-

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera Presents Positive Preclinical Data on ABCL575 at the SID Annual Meeting 2025...